Molecular diversity of macrophages in allergic reaction: Comparison between the allergenic modes; Th1- and -Th2-derived immune conditions

Iranian Journal of Allergy, Asthma and Immunology

Volumn 14, Issue 3, 2015, Pages 261-272

  Bagheri, Mozhdeh ^a   Dong, Yupeng ^a   Ono, Masao ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cell markers; Complete Freund Adjuvant; Cytokines; Hypersensitivity; Inflammatory; Macrophages; Ovalbumin alum; Th1 cells; Th2 cells

Indexed keywords

BIOLOGICAL MARKER; CELL SURFACE PROTEIN; CYTOKINE; FREUND ADJUVANT; IMMUNOGLOBULIN LIKE TYPE 2 RECEPTOR ALPHA; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; MACROPHAGE GALACTOSE N ACETYL GALACTOSAMINE SPECIFIC LECTIN 2; OVALBUMIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ALUMINUM POTASSIUM SULFATE; ALUMINUM SULFATE;

ALLERGIC REACTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPARATIVE STUDY; CYTOKINE PRODUCTION; DNA MICROARRAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; MACROPHAGE; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; TH1 CELL; TH2 CELL; ANIMAL; CELL POLARITY; HYPERSENSITIVITY; IMMUNOLOGY;

ALUM COMPOUNDS; ANIMALS; CELL POLARITY; FREUND'S ADJUVANT; HYPERSENSITIVITY; MACROPHAGES; MALE; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OVALBUMIN; TH1 CELLS; TH2 CELLS;

EID: 84929667255     PISSN: 17351502     EISSN: 17355249     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Wan YY. Multi-tasking of helper T cells. Immunology 2010;130(2):166-71.
2. Borek F, Silverstein AM, Gell PG. Delayed hypersensitivity to hapten-protein conjugates. III. saccharides as haptens. Proc Soc Exp Biol Med 1963;114:266-70.
3. Kitching AR, Holdsworth SR, Tipping PG. Crescentic glomerulonephritis-a manifestation of a nephritogenic Th1 response? Histol Histopathol 2000;15(3):993-1003.
4. Gordon S. Alternative activation of macrophages. Nature Rev Immunol 2003;3(1):23-35
5. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008;8(12):958-69.
6. Taubes G. Cancer prevention with a diabetes pill? Science 2012;335(6064):29.
7. Gordon S, Martinez FO. Alternative activation of macrophages: mechanism and functions. Immunity 2010;32(5):593-604.
8. Kidd P. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern Med Rev 2003;8(3):223-46.
9. Ebihara S, Kurachi H, Watanabe Y. A simple preparation method for mouse eosinophils and their responses to anti-allergic drug. Inflam Res 2007;56(3):112.7.
10. Raes G, Brys L, Dahal BK, Brandt J, Grooten J, Brombacher F, et al. Macrophage galactose-type C-type lectins as novel markers for alternatively activated macrophages elicited by parasitic infections and allergic airway inflammation. J Leukoc Boil 2005;77(3):321-7.
11. Eisenbarth SC, Piggott DA, Huleatt JW, Visintin I, Herrick CA, Bottomly K. Lipopolysaccharide-enhanced, toll-like receptor 4-dependent Thelper cell type 2 responses to inhaled antigen. J Exp Med 2002;196(12):1645-51
12. Osborn O, Olefsky JM. The cellular and signaling networks linking the immune system and metabolism in disease. Nat Med 2012;18(3):363-74.
13. Oh JY, Choi H, Lee RH, Roddy GW, Ylostalo JH, Wawrousek E, et al. Identification of the HSPB4/TLR2/NF-κB axis in macrophage as a therapeutic target for sterile inflammation of the cornea. EMBO Mol Med 2012;4(5):435-48.
14. Ford AQ, Dasgupta P, Mikhailenko I, Smith EM, Noben-Trauth N, Keegan AD. Adoptive transfer of IL-4Rα+ macrophages is sufficient to enhance eosinophilic inflammation in a mouse model of allergic lung inflammation. BMC Immunol 2012;13:6.
15. Austyn JM, Gordon S. F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur J Immunol 1981;11(10):805-15.
16. Fujisaka S, Usui I, Kanatani Y, Ikutani M, Takasaki I, Tsuneyama K, et al. Telmisartan improves insulin resistance and modulates adipose tissue macrophage polarization inhigh-fat-fed mice. Endocrinology 2011;152(5):1789-99.
17. Takai T. Paired immunoglobulin-like receptors and their MHC class I recognition. Immunology 2005;115(4):433-40.
18. Vassilatis DK, Hohmann JG, Zeng H, Li F, Ranchalis JE, Mortrud MT, et al. The G protein-coupled receptor repertoires of human and mouse. Proc Natl Acad Sci USA 2003;100(8):4903-8.
19. Jaeger K, Paulsen F, Wohlrab J. Characterization of cationic amino acid transporters (hCATs) 1 and 2 in human skin. Histochem Cell Biol 2008;129(3):321-9.
20. Stacey M, Chang GW, Sanos SL, Chittenden LR, Stubbs L, Gordon S, et al. EMR4, a novel epidermal growth factor (EGF)-TM7 molecule up-regulated in activated mouse macrophages, binds to a putative cellular ligand on B lymphoma cell line A20. J Biol Chem 2002;277(32):29283-93
21. Nagai K, Arai H, Yanagita M, Matsubara T, Kanamori H, Nakano T, et al. Growth arrest-specific gene 6 is involved in glomerular hypertrophy in the early stage of diabetic nephropathy. J Biol Chem 2003;278(20):18229-34.
22. Bobbie MW, Roy S, Trudeau K, Munger SJ, Simon AM, Roy S. Reduced connexin 43 expression and its effect on the development of vascular lesions in retinas of diabetic mice. Invest Ophthalmol Vis Sci 2010;51(7):3758-63.
23. Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 2007;117(1):175-84.
24. Hamann J, Kwakkenbos MJ, De Jong EC, Heus H, Olsen AS, Van Lier RA. Inactivation of the EGF-TM7 receptor EMR4 after the Pan-Homo divergence. Eur J Immunol 2003); 33(5):1365-71.